BioSpace News Archive

Pharm Country

HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting

HOOKIPA Pharma Inc. today announced that members of HOOKIPA’s Executive Team will host an investor call on June 4, 2024, at 4:15 p.m. ET.

May 30, 2024
·
5 min read
Lone Star Bio

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System

Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular Oncology Group (COOG2).

May 30, 2024
·
8 min read
Biotech Beach

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

Oncocyte Corporation, a precision diagnostics company, announced that favorable data regarding its lead product VitaGraft™ Kidney was published in the New England Journal of Medicine.

May 30, 2024
·
8 min read
Bio NC

Dentsply Sirona to Participate in Upcoming Investor Conferences - May 30, 2024

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its participation at upcoming conferences.

May 30, 2024
·
1 min read
Deals

Incyte Completes Acquisition of Escient Pharmaceuticals

Incyte (Nasdaq:INCY) today announced that it has completed its acquisition of Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders.

May 30, 2024
·
5 min read
BioMidwest

Neogen® to Participate in the 44th Annual William Blair Growth Stock Conference

Neogen announced today that the Company will participate in the 44th Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 4, 2024.

May 30, 2024
·
1 min read
Lone Star Bio

OncoNano Medicine To Present a Trials in Progress Poster for ON-5001 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Ongoing Phase 1/1b Clinical Trial Evaluating ONM-501, a Dual-activating STING Agonist, Alone and In Combination with Cemiplimab in Solid Tumors.

May 30, 2024
·
3 min read
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Mereo BioPharma Group plc today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00am ET / 04:00pm BST.

May 30, 2024
·
5 min read
Genetown

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

Pyxis Oncology, Inc. announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a fireside chat on Thursday, June 6, 2024 at 9:00 AM Eastern Time at the Jefferies Global Healthcare Conference in New York City.

May 30, 2024
·
3 min read
Pharm Country

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Carisma Therapeutics Inc. today announced that Steven Kelly , President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference.

May 30, 2024
·
1 min read